BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11939724)

  • 21. Quality control in cytologic screening.
    Cecchini S; Grazzini G; Bonardi R; Ciatto S
    Acta Cytol; 1993; 37(3):436. PubMed ID: 8498145
    [No Abstract]   [Full Text] [Related]  

  • 22. ["Papanicolaou." Outmoded, isn't it?].
    de León-Antoni E
    Bol Asoc Med P R; 1991 Oct; 83(10):462-4. PubMed ID: 1789893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Pap test terminology, management guidelines published.
    Twombly R
    J Natl Cancer Inst; 2002 Jun; 94(12):878-80. PubMed ID: 12072539
    [No Abstract]   [Full Text] [Related]  

  • 24. Response to "access to cervical cancer screening: training internists so skill limitations are not a barrier to care".
    Savard M
    J Womens Health (Larchmt); 2007 Apr; 16(3):429. PubMed ID: 17439388
    [No Abstract]   [Full Text] [Related]  

  • 25. Rapid review.
    Faraker CA
    Cytopathology; 1998 Apr; 9(2):71-6. PubMed ID: 9660635
    [No Abstract]   [Full Text] [Related]  

  • 26. Trial quickly changed management of cervical abnormalities.
    Zielinski SL
    J Natl Cancer Inst; 2005 Apr; 97(7):479-80. PubMed ID: 15812071
    [No Abstract]   [Full Text] [Related]  

  • 27. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
    van Kemenade FJ
    Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1752. PubMed ID: 18727611
    [No Abstract]   [Full Text] [Related]  

  • 28. [Reproducibility of cytologic diagnosis: study of CRISAP Ile-de-France].
    Barrès D; Bergeron C
    Gynecol Obstet Fertil; 2000 Feb; 28(2):120-6. PubMed ID: 10758586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The challenge of quality improvement with the Papanicolaou smear.
    Kline TS
    Arch Pathol Lab Med; 1997 Mar; 121(3):253-5. PubMed ID: 9111111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality control in cytopathology applied to screening for cervical carcinoma.
    Marsan C
    Pol J Pathol; 1995; 46(4):245-8. PubMed ID: 8713292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for cervical cancer: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am J Nurs; 2003 Nov; 103(11):101-2, 105-6, 108-9. PubMed ID: 14625432
    [No Abstract]   [Full Text] [Related]  

  • 32. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
    Kwee WS; van der Putten HW; Mieremet RH; de Kniff P
    Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1751-2; author reply 1752. PubMed ID: 18727610
    [No Abstract]   [Full Text] [Related]  

  • 33. Quality assessment in the age of machine-aided cervical cytology screening.
    Renshaw AA
    Cancer; 2004 Dec; 102(6):345-7. PubMed ID: 15540251
    [No Abstract]   [Full Text] [Related]  

  • 34. The gynecologist's perspective of liability and quality issues with the Papanicolaou smear.
    Greer BE
    Arch Pathol Lab Med; 1997 Mar; 121(3):246-9. PubMed ID: 9111109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality assurance in cytopathology. Recommendations and ongoing quality assurance activities of the American Society of Clinical Pathologists.
    Bonfiglio TA
    Acta Cytol; 1989; 33(4):431-3. PubMed ID: 2750429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
    Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
    Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recommendations from the experimental sites for implementing organized cervical cancer screening in France].
    Baudier F; Schapman S; Giordanella JP
    Sante Publique; 2000 May; 12 Spec No():71-88. PubMed ID: 10989630
    [No Abstract]   [Full Text] [Related]  

  • 38. NCI makes changes in the Bethesda System.
    Am Fam Physician; 1992 Sep; 46(3):967-8. PubMed ID: 1514480
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
    Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
    Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality assurance in cervical cytopathology.
    Light AM
    Cytopathology; 1997 Aug; 8(4):290-2. PubMed ID: 9252748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.